To view AHRP news and infomails from 2006, please visit our new site. Infomails Subscribe to AHRP’s infomails At FDA, Graham is still the whistle-blower Loss of Trust: Big Drug Makers See Sales Decline With Their Image War hero’s death in clinical trial follows years of FDA neglect European perspective:…
Antidepressant drugs Used as Placebos! Fri, 10 Oct 2003 Increased use of antidepressant drugs during the 1990s, has increased national spending on antidepressant drugs by a walloping 600%! Dr. Jay Pomerantz of Harvard writes, “inappropriate use of antidepressant drugs may lead to a deterioration of clinical course with no clear…
Schizophrenia Drug Implants May Qualify as Medical Torture Sun, 17 Nov 2002 In some patients, antipsychotic drugs induce excruciating, intolerable side-effects. In some people these drugs’ toxic action has caused severe liver, heart, and kidney damage, as well as dangerously high blood pressure– some patients have died as a result…
Drugging Our Kids – New American Mon, 25 Aug 2003 A powerful article in the current New American holds a mirror to the irresponsible medical involvement of school officials and what has become common practice of forcing children to swallow psychotropic drugs. “Despite the dangers posed by drugs such as…
Go Slow on Mental Health Screening: Dr. Karen Effrem responds to New Freedom Commission Chair, Michael Hogan – Wash Times Sun, 31 Oct 2004 A letter to the editor in the Washington Times – Go slow on Mental Health Screening – by AHRP’s newest board member, pediatrician Dr. Karen Effrem,…
Drug safety Hearings-Sept-Congress/ FDA – Lilly Plans to Disclose Data Tue, 3 Aug 2004 A hearing about the possible connection between suicide and antidepressant drugs will be held on Aug 4, by the California Senate by Sen. Tom Torkalson, chairman of the Senate Task Force on Youth and Workplace Wellness…
Lilly Consultants dismiss significance of suicide risk while Lilly will issue Black Box warning label for Strattera Mon, 10 Oct 2005 On September 29, the FDA issued the public health advisory alerting health care professionals that children and adolescents taking Strattera prescribed for ADHD should be closely monitored for changes…
AMA Serves Pharma Marketing Priority/ FDA To Add Warnings on ADHD drugs–Concerta, Ritalin, Strattera, Adderall Wed, 29 Jun 2005 The FDA is finally taking note of the fact that many drugs prescribed for the treatment of psychiatric problems are CAUSING serious psychiatric and cardiovascular problems in children and adolescents !…
Media Release: Congressional Staff Briefing Re: Mental Health Screening for Children Mon, 7 Feb 2005 ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) Promoting Openness, Full Disclosure, and Accountability www.ahrp.org MEDIA RELEASE For Immediate Release Monday, February 7, 2005 Congressional Staff Briefing : Mental Health Screening for Children In the last Congress,…
Lilly to Add Suicide Warning to Strattera – Medicaid May shrink $5.5 Billion spending on Schizophrenia Drug Thu, 29 Sep 2005 Reuters reports that Eli Lilly is adding a Black Box suicide warning to the Strattera label. Strattera has been promoted as a “non stimulant” treatment for ADHD. Since ADHD…
Treating children as young as 4 for bipolar – WSJ Thu, 26 May 2005 A report in The Wall Street Journal should raise serious concerns about the legitimacy of psychiatric diagnosing and drug prescribing for children. The Journal reports that close to 20,000 US children are being diagnosed with bi-polar…
AHRP InfoMail Declaration of Helsinki Nuremberg Code Hippocratic Oath Return to Home Page Prescribing Ritalin for Pre-Schoolers FYI A Feb. 4, 2002 press release by The National Institutes ofHealth (NIH) announces a new "finding" by researchers from theNational Institute of Environmental Health Resources (NIEHR). They claim that"more than 15 percent…
